Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis

Rheumatology

Volumn 48, Issue 1, 2009, Pages 61-64

  Nevskaya, Tatiana ^a,b   Ananieva, L ^a   Bykovskaia, S ^a   Eremin, I ^a   Karandashov, E ^a   Khrennikov, J ^a   Mach, E ^a   Zaprjagaeva, M ^a   Guseva, N ^a   Nassonov, E ^a  

^a V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^b NONE   (Russian Federation)

Author keywords

Angiogenesis; Endothelial progenitors; Fingertip ulcers; Stem cells; Systemic sclerosis; Therapy

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; FENTANYL; METHYLPREDNISOLONE; PENICILLAMINE; PENTOXIFYLLINE; PROSTAGLANDIN; PROSTAGLANDIN E1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VASCULOTROPIN RECEPTOR 2; VASODILATOR AGENT;

ADULT; ANGIOGENESIS; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; BRACHIAL ARTERY; CASE REPORT; CD34 SELECTION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; ECHOGRAPHY; ENDOTHELIUM; FEASIBILITY STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FUNCTIONAL STATUS; HAND DISEASE; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; ISCHEMIA; LASER DOPPLER FLOWMETRY; MICROCIRCULATION; MONONUCLEAR CELL; OPEN STUDY; PAIN ASSESSMENT; PATIENT SAFETY; PHYSICAL DISABILITY; PILOT STUDY; PRIORITY JOURNAL; PROTECTION; RAYNAUD PHENOMENON; SKIN BLOOD FLOW; SKIN SURFACE; SKIN TEMPERATURE; SKIN ULCER; STEM CELL; STEM CELL MOBILIZATION; SYSTEMIC SCLEROSIS; THERMOGRAPHY; ULCER HEALING; VISUAL ANALOG SCALE;

ADULT; ANTIGENS, CD34; FEASIBILITY STUDIES; FEMALE; FINGERS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; ISCHEMIA; MICROCIRCULATION; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN; SKIN ULCER; TREATMENT OUTCOME;

EID: 57349084998     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken407     Document Type: Article

References (11)

1. Kuwana M, Okazaki Y, Yasuoka H et al. Defective vasculogenesis in systemic sclerosis. Lancet 2004;364:603-10.
2. Kudo FA, Nishibe T, Nishibe M et al. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003;22:344-8.
3. Huang PP, Yang XF, Li SZ et al. Randomized comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007;98:1335-42.
4. Valentini G, Bencivelli W, Bombardieri S et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003;62: 901-3.
5. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
6. Lin GS, Lü JJ, Jiang XJ et al. Autologous transplantation of bone marrow mononuclear cells improved heart function after myocardial infarction. Acta Pharmacol Sin 2004;25:876-86.
7. Higashi Y, Kimura M, Hara K et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004;109:1215-8.
8. Kamata Y, Takahashi Y, Iwamoto M et al. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology 2007;46:882-4.
9. Yamamoto K, Kondo T, Suzuki S et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol 2004;24:e192-6.
10. Kuwana M, Kaburaki J, Okazaki Y et al. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum 2006;54:1946-51.
11. Saigawa T, Kato K, Ozawa T et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004;68:1189-93.